SPRUCE BIOSCIENCES, INC.
A clinical-stage biopharma developing therapies for underserved neurological disorders.
SPRB | US
Overview
Corporate Details
- ISIN(s):
- US85209E1091
- LEI:
- Country:
- United States of America
- Address:
- 611 GATEWAY BOULEVARD, SUITE 740, 94080 SOUTH SAN FRANCISCO
- Website:
- https://sprucebio.com/
Description
Spruce Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for serious, underserved neurological disorders. The company's mission is to advance targeted, first-in-class treatments to address significant unmet medical needs. Its lead investigational therapy, TA-ERT, is being advanced for conditions such as MPS IIIB (Sanfilippo Syndrome Type B), a rare and progressive neurological disease. Guided by a patient-centric approach, Spruce Biosciences aims to develop transformative therapies that offer meaningful outcomes beyond conventional approaches.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SPRUCE BIOSCIENCES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SPRUCE BIOSCIENCES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SPRUCE BIOSCIENCES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
